TAUNS Laboratories, Inc. Logo

TAUNS Laboratories, Inc.

Develops and sells in vitro diagnostics and research reagents, like antigen tests, globally.

197A | T

Overview

Corporate Details

ISIN(s):
JP3452250008
LEI:
Country:
Japan
Address:
伊豆の国市神島761番1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TAUNS Laboratories, Inc., founded in 1987, is a company engaged in the development, manufacture, and sale of in vitro diagnostics (IVD) and research reagents. The company's mission is to enrich lives and provide peace of mind through its proprietary diagnostic technologies. Its main products include antigen test kits for infectious diseases and various analytical reagents. A key focus for the company is the development of patient-friendly products for global consumption, facilitated through its export and import operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 09:49
Registration Form
確認書
Japanese 8.1 KB
2025-09-25 09:47
Annual Report
有価証券報告書-第10期(2024/07/01-2025/06/30)
Japanese 2.0 MB
2025-02-13 07:30
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-02-13 07:30
Interim Report
半期報告書-第10期(2024/07/01-2025/06/30)
Japanese 174.5 KB
2024-09-30 03:19
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-09-27 08:00
Registration Form
確認書
Japanese 8.1 KB
2024-09-27 08:00
Governance Information
内部統制報告書-第9期(2023/07/01-2024/06/30)
Japanese 22.1 KB
2024-09-27 08:00
Annual Report
有価証券報告書-第9期(2023/07/01-2024/06/30)
Japanese 1.9 MB
2024-06-12 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-06-04 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-05-17 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 4.7 MB

Automate Your Workflow. Get a real-time feed of all TAUNS Laboratories, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TAUNS Laboratories, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TAUNS Laboratories, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland
CLN
CEL SCI CORP Logo
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea
083790
CG Oncology, Inc. Logo
Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea
261780

Talk to a Data Expert

Have a question? We'll get back to you promptly.